Navigation Links
Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary
Date:11/13/2007

(p=0.24) (p=0.15) (p=0.23) (p=0.41) (p=0.60) (p=0.33)

ApoA-1 0% 0% -6% 1% 2% -6% -5%

(p=0.59) (p=0.66) (p=0.93) (p=0.67) (p=0.43) (p=0.04)

TC 2% 5% -15% -13% -42% -34% -23%

(p=0.72)(p=0.005) (p=0.009) (p<0.0001)(p=0.0001)(p=0.0001)

TG 0% 4% 4% -25% -41% -35% -15%

(p=0.60) (p=0.52) (p=0.38) (p=0.04) (p=0.02) (p=0.92)

P value = vs. placebo

* Primary endpoint analysis was 30 day post last dose, Day 59, in

cohorts treated for 5 weeks and 14 days post last dose, Day 99, in the

cohort treated for 13 weeks

** Per protocol, analysis excludes one patient enrolled in the

400 mg/week cohort who dropped out after receiving only one dose of

study drug

*** Statistical analysis of the 200 mg/week dose group treated for 13

weeks is versus a pooled placebo from all cohorts (n=14)

Table 2: Mipomersen Phase 1 and Phase 2 Summary of On-Treatment ALT

Elevations*

Percentage of subjects with ALT elevations

Max ALT** Placebo 30/50 100 200 >=300

mg/week mg/week mg/week mg/week

(N=40) (N=35) (N=35) (N=87) (N=106)

150-250 3% 3% 0% 3% 7%

IU/L

(3xULN-

5xULN***)

>250 IU/L 0% 0% 0% 0% 0%

(>5xULN***)

* On-treatment period encompasses the treatment period from first dose

to last dose

** Each subject is counted only once at maximum ALT reading

*** ULN is defined to be 50 IU/L

Table 3: Mipomersen Phase 1 and Phase 2 Summary of Entire Study ALT

Elevations*

Percentage of subj
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 2014  Tokyo-based Atonarp Inc. announced today $8 ... by Walden Riverwood Ventures with participation from other ... Smart Spectrometer technology platform, which will enable a ... the oil & gas and healthcare industries for ... to partner with Atonarp in pursuing the commercialization ...
(Date:8/19/2014)... 2014  Boehringer Ingelheim today announced that the ... review the New Drug Application (NDA) for the ... via the Respimat ® inhaler for the ... airflow obstruction in patients with chronic obstructive pulmonary ... + olodaterol FDC will not be indicated to ...
(Date:8/19/2014)...  Cardiva Medical, Inc. announced today that it has ... Series 3 private equity financing and a $12.5 million ... use the proceeds of the Series 3 private equity ... its VASCADE® Vascular Closure System in the ... Series 3 private equity financing was a new investor, ...
Breaking Medicine Technology:Atonarp Inc. Raises $8M Series A Round Led by Walden Riverwood Ventures 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 4Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 5Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 6Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 7Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 8Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital 2
... a just-released National Minority Quality Forum Issue Brief ... Gary Puckrein and Gretchen Wartman examine specialty ... and private) as a benefit-management tool to limit their ... certain high-cost prescription drugs. The authors remind us that, ...
... cable network dedicated to serving the needs of Generation 50+, will ... You: Your Questions, Your Choices on August 15 at ... will turn 65 and become eligible for Medicare every day for ... Signing up for Medicare means making choices, and for many, the ...
Cached Medicine Technology:Prescription-Drug Plans' Use of Specialty Tiers Promotes Inequalities 2Making Medicare Work for You: Your Questions, Your Choices 2Making Medicare Work for You: Your Questions, Your Choices 3
(Date:8/20/2014)... B. E. Smith, the only full-service ... been retained to lead a national chief operating ... in Hermiston, Ore. The top executive search firm ... recently placed more than 900 healthcare executives into organizations. ... progressive, not-for-profit healthcare organization serving a population of more ...
(Date:8/20/2014)... DC (PRWEB) August 20, 2014 Hope ... Heart, Give Hope® Celebration to be hosted in Washington, ... and Navy Club. This signature event honors the courage ... families of the fallen. Proceeds from the Got Heart, ... a national nonprofit dedicated to restoring a sense of ...
(Date:8/20/2014)... August 20, 2014 Inc. Magazine ... on its 33rd annual Inc. 500|5000, an exclusive ... list represents the most comprehensive look at the ... Companies such as Yelp, Pandora, Timberland, Dell, Domino’s ... gained early exposure as members of the Inc. ...
(Date:8/20/2014)... 2014 Building on growing success ... predicted stage iii and iv pressure ulcers with ... approached 90%. A company spokesperson commented that these ... or academic settings. The resulting capabilities can be ... hospital-acquired conditions to help providers avoid financial losses ...
(Date:8/20/2014)... August 20, 2014 Ticketability.com ... public at fair prices. The well-known medium has been ... is now touring in 19 cities, with tickets becoming ... television personality will visit are Albany, Baltimore, Trenton, Erie, ... Albuquerque, Beverly Hills and San Diego. The medium’s fans ...
Breaking Medicine News(10 mins):Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 2Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 3Health News:Hope For The Warriors Announces Got Heart, Give Hope Celebration in Washington, DC 2Health News:Etransmedia Makes Exclusive List for the Eighth Consecutive Year in Inc. Magazine 2Health News:Etransmedia Makes Exclusive List for the Eighth Consecutive Year in Inc. Magazine 3Health News:Jvion Achieves Benchmark Accuracy in Pressure Ulcer Prediction 2Health News:Theresa Caputo Tour Tickets for Sale at Ticketability.com Cause a Buying Frenzy Among Customers Over Their Offering of Deeply Discounted Seats 2
... Office of Naval Research are working on using virtual ... Disorder (PTSD). //, ,In this research, scientists are ... from PTSD to go through the similar experiences they ... the traumatic experience that had left them unable to ...
... the declining numbers of infants in the Middle East ... first six months of their lives.//, ,"Several high-income ... Qatar, Oman, the UAE and Saudi Arabia maintain patterns ... below 35 percent," Unicef said in a statement released ...
... very active leisure time can reduce the chances of having ... from National Public Health Institute in Helsinki, Finland, had reported ... Heart Association., ,Researchers had looked into the data provided ... 25 to 64 years, all of them healthy and without ...
... the University of Arkansas, Worcester Polytechnic Institute //and other ... to examine the fossils of our ancestors’ teeth to ... and why. ,By comparing teeth from two species ... researchers confirm previous evidence that A. africanus ate more ...
... change in the genetic constitution is what makes each ... is unraveled, then health care can be individualized according ... same genetic code, how those genes express themselves at ... medicines and dietary advice. According to a recent study, ...
... Nebraska, was slated for a slow but sure death, weighing in ... or even turn over in bed. , ,Deuel is now ... than 200 kg after undergoing an operation that is becoming increasingly ... opera singer, Deborah Voigt, also lost 50 kg after she underwent ...
Cached Medicine News:Health News:Breastfeeding Decline In Middle East Worries UN 2Health News:Physical Activity During Leisure Can Reduce Risk Of Stroke 2Health News:Scientists Develop New Technology To Find About Human Ancestors’ Teet 2Health News:Learning Just How Different We Are 2Health News:Obesity better handled with gastric bypass surgery 2
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
... acetabular cup system has been designed to ... tri-spiked and cluster hole configurations. The objective ... micromotion on three primary modes: Tilt, migration ... features result in initial and long-term fixation. ...
The Biopro All Poly cup is a uniquely designed UHMWPE acetabular cup....
The Plasmacup SC satisfies two important requirements: high primary stability and a low friction bearing surface....
Medicine Products: